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Abstract: Kiamycin (1), a new angucyclinone derivative possessing an   
1,12-epoxybenz[a]anthracene ring system, was isolated from the marine Streptomyces sp. 
strain M268 along with the known compounds 8-O-methyltetrangomycin (3) and   
8-O-methylrabelomycin (4). Their structures were elucidated by detailed spectroscopic 
analysis and comparison with literature data. The new angucyclinone derivative showed 
inhibitory activities against the human cell lines HL-60 (leukemia), A549 (lung 
adenocarcinoma), and BEL-7402 (hepatoma) with inhibition rates of 68.2%, 55.9%, and 
31.7%, respectively, at 100 µM. It appears to have potential as an anticancer agent with 
selective activity. 
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1. Introduction 
Angucyclinones, benz[a]anthraquinone derivatives isolated mainly from Streptomyces spp. [1], 
have attracted much attention due to their broad and strong biological activities, mainly as antiviral, 
antifungal, anti-tumor and enzyme inhibitory drugs [2,3]. Up to now, more than 100 angucyclinones 
have been described since the discovery of tetrangomycin and tetrangulol in 1965 [3,4]. However, less 
than 20 of them possess epoxybenz[a]anthraxcene structures, and most of the latter are   
6a,12a-epoxides. Among the others, gephyromycin (2) is of some interest because of its remarkable 
structure. It was isolated from a Streptomyces sp. by Bringmann et al. in 2005 and was found to exhibit 
glutaminergic activity on neuronal cells [5].  
In our investigation of marine microbes in Kiaochow Bay of China, a Streptomyces strain M268 
yielded a further unique angucyclinone derivative, a 1,12-epoxybenz[a]anthracene (1). In this paper, 
we report the isolation, structure elucidation and cytotoxicity of compound 1 (Figure 1) against the 
human cell lines HL-60 (leukemia), BEL-7402 (hepatoma), and A549 (lung adenocarcinoma). 
Figure 1. Structures of kiamycin (1); gephyromycin (2); 8-O-methyltetrangomycin (3); 
and 8-O-methylrabelomycin (4). 
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2. Results and Discussion 
2.1. Isolation and Structure Elucidation of Kiamycin 
The streptomycete strain M268 was isolated from a marine sediment sample collected near Qingdao 
and cultivated on M2
+ medium with aged seawater. After 7 days at 28 °C, the culture filtrate and the 
mycelium were extracted with ethyl acetate, and the combined extracts were separated by silica gel 
column chromatography. The nonpolar first fraction was further purified by column chromatography 
on Sephadex LH-20 and reversed phase RP-18, and by preparative TLC to deliver the colorless UV 
absorbing 1 and two orange angucyclinones 3 and 4. 
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Compound  1 was obtained as colorless powder with a negative sign of optical rotation   
([]
25
D α  = –113.9; c 0.01, MeOH); the molecular formula was established as C20H18O4 by HRESIMS of 
the pseudomolecular ion peak at m/z 345.1103 [M + Na]
+ (calcd for C20H18O4Na: 345.1097). The  
1H NMR and COSY spectra indicated a 1,2,3-trisubstituted benzene ring by signals of o-coupled 
protons at δ 6.85 (d), 7.18 (d), and 7.38 (t); the expected m-coupling was not visible but was indicated 
by a line broadening and was visible in the COSY spectrum. A second benzene unit was connected 
with a methyl group (δ 2.24, s), which was flanked by two protons (broadened singlets at δ 6.41 and 
6.50), as indicated by long-range couplings among each other and with the methyl group, respectively, 
and by NOE correlations with 3-Me. The 9.5 Hz coupling constant of two further doublets at δ 5.88 
and 6.74 indicated a cis-configured double bond. Finally, a methoxy singlet appeared at δ 3.80, and 
signals of three oxymethine protons were seen at δ 4.11 (d), 4.85 (d), and 6.00 (d); the residual two 
hydrogen atoms should belong to hydroxy groups.  
The 
13C NMR and DEPT spectra of 1 revealed the expected 20 carbon signals, which were 
classified as two methyls, ten methines, and one oxygenated tertiary carbon (δ 75.8); the remaining seven 
signals belonged to aromatic tertiary carbons (Table 1). As the molecular formula required 12 double 
bond equivalents, together with the partial structures mentioned above, compound 1 must be pentacyclic. 
Table 1. 
1H, 
13C, Correlated Spectroscopy (COSY) and Heteronuclear Multiple Bond 
Correlation (HMBC) NMR data of kiamycin (1) in CDCl3. 
Position  δC, assignm.  δH, mult.  
(J in Hz)  
1H–
1H COSY  HMBC 
1  156.7, Cq      
2  110.5, CH  6.41, s br  H-4, 3-CH3  C-1, C-4, C-12b, 3-CH3 
3  140.1, Cq      
4  117.6, CH  6.50, s br  H-2, 3-CH3  C-2, C-5, C-12b, 3-CH3 
4a  131.5, Cq      
5  130.0, CH  6.74, d (9.5)  H-6  C-4, C-4a, C-6a, C-12b 
6  134.9, CH  5.88, d (9.5)  H-5  C-4a, C-12a 
6a  75.8, Cq      
7  66.4, CH  4.85, d (1.5)  H-12a  C-6a, C-7a, C-8, C-11a, C-12a 
7a  125.5, Cq      
8  158.3, Cq      
9  111.0, CH  6.85, d (8.3)  H-10, H-11  C-7a, C-8, C-11 
10  130.1, CH  7.38, t (7.9)  H-9, H-11  C-8, C-11a 
11  123.3, CH  7.18, d (7.9)  H-9, H-10  C-7a, C-9, C-12 
11a  133.0, Cq      
12  82.6, CH  6.00, d (10.4)  H-12a  C-1, C-6a, C-7a, C-11, C-11a, 
C-12a, C-12b 
12a  44.0, CH  4.11, d (10.4)  H-7, H-12  C-6a, C-7, C-11a, C-12b 
12b  122.0, Cq      
8-OCH3  55.9, CH3  3.80, s   C-8 
3-CH3  22.0, CH3  2.24, s  H-2, H-4  C-2, C-3, C-4 
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Both the methoxy signal and the triplet of H-10 showed HMBC couplings with the same carbon at  
δ 158.3, which assigned the methoxy group to C-8. Further HMBC signals (see Figure 2) with key 
correlations from H-12 to C-11 (and vice versa), and from H-7 to C-8 resulted in an oxygenated 
tetraline sub-structure (rings A and B in 1). Cross signals of the double bond protons extended this 
system by ring C and allowed the attachment of ring D only in an angular manner, resulting in the 
carbon skeleton of a non-quinonoid anthracyclinone derivative. The positions of the substituents were 
additionally confirmed by NOE contacts between 3-Me and H-2/4, by correlations of OMe with H-7 
and H-9, and of H-6 with H-7. This agrees well with 8-O-methyltetrangomycin (3) and   
8-O-methylrabelomycin (4), isolated from the same strain in parallel. The structures of the latter were 
elucidated by spectral data and comparison with literature values [6]. 
Figure 2. HMBC and COSY correlations (left) and NOESY correlations (right) of kiamycin (1). 
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Four oxygenated carbon atoms (C-1, 6a, 7, 12) still had open bonds (partial structure 5 in Figure 3). 
As only three oxygen atoms were left and only 2 OH groups can be expected according to the proton 
number, the residual double bond equivalent must be due to a ring closure between two of these 
carbons via an oxygen bridge, while the OH groups are connected with the remaining two downfield 
carbons: Rings could be formed between C-1/12 (6a,7-OH), C-6a/7 (1,12-OH), C-6a/12 (1,7-OH), and 
C-7/12 (1,6a-OH), where the numbers in brackets indicate the position of the additional OH groups. It 
is obvious that in three of these cases a phenol is formed at C-1, which should easily be methylated 
with diazomethane. However, as no methyl ether was formed under standard conditions, 1 is the only 
remaining plausible structure. 
Figure 3. Partial structure 5 of kiamycin (1) with four open valences; C* = oxygenated 
carbon; 6 = X-14881F. 
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The relative configuration of 1 was tentatively derived from coupling constants and NOE 
correlations: The large coupling constant (9.5 Hz) between H-12 and H-12a and the strong NOE 
between these atoms agrees best with a dihedral angle close to 0° (cis-configuration), which requires a 
trans-orientation of the furan C-12/O bond. Protons H-7 and H-12a are showing a strong W-coupling 
(J = 1.6 Hz), which requires a coplanar orientation of the connecting bonds. This is achieved only if 
rings B and C are also cis-fused; in agreement with the experiment, no NOE is expected between H-7 
and H-12 or H-12a in this configuration, as H-7 is too far away. Compound 1 is therefore rel-
(5aR,6R,10bR,11cS)-7-methoxy-2-methyl-10b,11c-dihydro-6H-11-oxa-benzo[bc]aceanthrylene-5a,6-diol, 
which we suggest to name kiamycin. For better comparison, we are using the conventional 
angucycline numbering in this paper. 
The biosynthesis of 1 has not yet been investigated. A plausible approach is, however, the 
cyclisation of a precursor like saccharithrixin C, elmycin E, or the recently isolated X-14881F (6) [7], 
and the successive loss of water. While these precursors might end up with a wrong configuration of 1, 
panglimycin B (7) [8] should deliver the correct stereochemistry (Figure 4). 
Figure 4. Hypothetical biotransformation of panglimycin B (7) into kiamycin (1). 
7    1 
To date, eight natural epoxybenz[a]anthracene derivatives have been described, seven of which 
were isolated from Streptomyces spp. [5,8–12]. None of them has an 11-oxabenzo[bc]aceanthrylene 
skeleton like 1. However, a similar benzofuran was formed easily as an intermediate in the synthesis of 
hatomarubigin [13]. 
2.2. Biological Activity  
In the cytotoxicity tests, kiamycin (1) exhibited activity against human cell lines, namely HL-60 
(leukemia), lung adenocarcinoma cells A549, and the hepatoma cell line BEL-7402 with inhibition 
values of 68.2%, 55.9%, and 31.7% at 100 μM; adriamycin as positive control showed inhibition rates 
of 70.0%, 79.3%, and 80.0%, respectively (Table 2). Both compounds were equivalently cytotoxicity 
against HL-60, while 1 had significantly weaker inhibitory effects against A549 and BEL-7402, as 
indication of a selective cytotoxicity. 
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Table 2. Cytotoxicity of kiamycin (1) and adriamycin against human cell lines HL-60 
(leukemia), BEL-7402 (hepatoma), and A549 (lung adenocarcinoma) at 10
−4 M. 
Cancer Cell Line  Inhibition Rate by 1 (%)  Inhibition Rate by 
Adriamycin (%) 
human leukemic cell line HL-60  68.8  70.0 
human hepatoma cell line BEL-7402  31.7  79.3 
human lung adenocarcinoma cell line A549 55.9  80.8 
3. Experimental Section  
3.1. General 
Optical rotations were determined with a Perkin-Elmer polarimeter (model 243). 
1H NMR spectra 
were recorded on a Varian Inova 300 spectrometer at 300 MHz, 
13C NMR spectra were recorded with 
a Bruker Avance 500 spectrometer at 125.7 MHz. Chemical shifts were measured relatively to 
tetramethylsilane (TMS) as internal standard. 2D NMR spectra: H,H COSY spectra (
1H,
1H Correlated 
Spectroscopy), HMBC spectra (Heteronuclear Multiple Bond Correlation), HSQC spectra (Heteronuclear 
Single Quantum Coherence) and NOESY spectra (Nuclear Overhauser Effect Spectroscopy). ESI MS 
was recorded on a Finnigan LCQ with quaternary pump Rheos 4000 (Flux Instrument). ESI HRMS 
was performed on a Micromass LCT mass spectrometer coupled with a HP1100 HPLC with a diode 
array detector, or on an Apex IV 7 Tesla Fourier-Transform Ion Cyclotron Resonance Mass 
Spectrometer (Bruker Daltonics, Billerica, MA, USA).  
Sephadex LH-20 (Amersham Biosciences, Uppsala, Sweden), ODS-A (YMS, 100A, 50 µm), silica 
gel (Merck) 60-120 mesh for column chromatography, and pre-coated TLC sheets (layer thickness  
0.2 mm) and preparative TLC plate (layer thickness 1.25 mm) of silica gel 60 GF254 were used. Spots 
were detected on TLC under UV light or by heating after spraying with 5% H2SO4 in methanol. 
3.2. Isolation of the Producing Strain 
The marine Streptomyces sp. M268 was isolated on Gause’s synthetic agar medium (soluble starch 
20 g, KNO3 1 g, K2HPO4 0.5 g, MgSO4·7H2O 0.5 g, FeSO4·7H2O 0.01 g, K2Cr2O7 0.3 g, seawater  
500 mL, deionized water 500 mL, pH 7.4) from marine sediments of Kiaochow Bay, Qingdao. The 
strain is preserved within the biological resources department, Yantai Institute of Coastal Zone 
Research, Chinese Academy of Sciences.  
3.3. Fermentation and Isolation 
A pre-culture grown on M2
+ agar medium (malt extract 10 g, yeast extract 4 g, anhydrous glucose  
4 g, agar 15 g, deionized water 500 mL, seawater 500 mL) at 28 °C for 2 days was used to inoculate  
20 L of M2
+ medium. The fermentation was performed in 1 L Erlenmeyer flasks (250 mL broth each) 
on a linear shaker (120 rpm) for 7 days at 28 °C. 
The culture broth was filtered to separate mycelium and water phase. The water phase was 
extracted with ethyl acetate. The mycelium was dried at 50 °C, and extracted three times with ethyl 
acetate under ultrasonic radiation. Both extracts were combined, dissolved in methanol and defatted Mar. Drugs 2012, 10  557 
 
with cyclohexane. The evaporation residue (3.7 g) from the MeOH layer was separated by CC on silica 
gel with a CH2Cl2-MeOH (100:0→50:50) gradient to provide seven fractions (Fr.1-7). Fr.1 (0.26 g) 
was further purified by Sephadex LH-20 column chromatography (MeOH) and reversed phase RP-18 
column chromatography with a stepwise gradient of MeOH-H2O (20:80→100:0) to provide ten 
fractions (Fr.1a-1j). Fraction 1e (37.6 mg) was further purified by PTLC with CH2Cl2-MeOH (98:2) to 
yield 8-O-methyltetrangomycin (3, 17.5 mg, Rf = 0.3, CH2Cl2-MeOH (95:5)), and fraction 1f (20 mg) was 
further purified by PTLC with CH2Cl2-MeOH (98:2) to yield kiamycin (1, 6.3 mg, Rf = 0.4,   
CH2Cl2-MeOH (95:5)) and 8-O-methylrabelomycin (4, 2.6 mg, Rf = 0.3, CH2Cl2-MeOH (95:5)).  
3.5. Cytotxicity Tests  
Cytotxicity tests were carried out according to the method previously described by Zhang et al. [14] 
with slight modification: Kiamycin (1) solutions (2 μL in MeOH) were added to each well and further 
incubated for 72 h under the same conditions at the concentration of 10
−4 M. 
4. Conclusions  
A new angucycline derivative, kiamycin (1), possessing an 1,12-epoxybenz[a]anthracene ring 
system, was isolated from the marine Streptomyces sp. M268. This is the first report of this skeleton 
from nature. The new compound 1 exhibited cytotoxic activities against three human cell lines, 
including leukemia HL-60, lung adenocarcinoma A549, and hepatoma cell line BEL-7402.  
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